{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T15:36:16Z","timestamp":1780414576009,"version":"3.54.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T00:00:00Z","timestamp":1715126400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T00:00:00Z","timestamp":1715126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s10549-024-07344-4","type":"journal-article","created":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T13:02:23Z","timestamp":1715173343000},"page":"103-109","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Left ventricular global longitudinal strain is worse in BRCA mutation positive breast cancer patients prior to cancer treatment and premature menopause"],"prefix":"10.1007","volume":"207","author":[{"given":"Billy","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"LeVee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louie","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reva","family":"Basho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balaji","family":"Tamarappoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chrisandra","family":"Shufelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,8]]},"reference":[{"issue":"2","key":"7344_CR1","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s11936-018-0609-z","volume":"20","author":"KC Gast","year":"2018","unstructured":"Gast KC et al (2018) Cardiovascular concerns in BRCA1 and BRCA2 mutation carriers. Curr Treat Options Cardiovasc Med 20(2):18","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"7344_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/genes8020059","author":"M Sajjad","year":"2017","unstructured":"Sajjad M et al (2017) An exploratory study to determine whether BRCA1 and BRCA2 mutation carriers have higher risk of cardiac toxicity. Genes (Basel). https:\/\/doi.org\/10.3390\/genes8020059","journal-title":"Genes (Basel)"},{"issue":"12","key":"7344_CR3","doi-asserted-by":"publisher","first-page":"e1002193","DOI":"10.1371\/journal.pmed.1002193","volume":"13","author":"T Jiang","year":"2016","unstructured":"Jiang T et al (2016) Predictors of chemosensitivity in triple negative breast cancer: an integrated genomic analysis. PLoS Med 13(12):e1002193","journal-title":"PLoS Med"},{"issue":"1","key":"7344_CR4","doi-asserted-by":"publisher","first-page":"7073","DOI":"10.1038\/s41598-020-63759-1","volume":"10","author":"S De Talhouet","year":"2020","unstructured":"De Talhouet S et al (2020) Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes. Sci Rep 10(1):7073","journal-title":"Sci Rep"},{"key":"7344_CR5","doi-asserted-by":"publisher","first-page":"833171","DOI":"10.3389\/fcvm.2022.833171","volume":"9","author":"BG Demissei","year":"2022","unstructured":"Demissei BG et al (2022) BRCA1\/2 mutations and cardiovascular function in breast cancer survivors. Front Cardiovasc Med 9:833171","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"7344_CR6","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s10549-016-4101-8","volume":"162","author":"EJ Pearson","year":"2017","unstructured":"Pearson EJ et al (2017) The incidence of cardiomyopathy in BRCA1 and BRCA2 mutation carriers after anthracycline-based adjuvant chemotherapy. Breast Cancer Res Treat 162(1):59\u201367","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"7344_CR7","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s10549-016-3678-2","volume":"155","author":"A Barac","year":"2016","unstructured":"Barac A et al (2016) Cardiac function in BRCA1\/2 mutation carriers with history of breast cancer treated with anthracyclines. Breast Cancer Res Treat 155(2):285\u2013293","journal-title":"Breast Cancer Res Treat"},{"issue":"10","key":"7344_CR8","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1097\/gme.0b013e3182517bd0","volume":"19","author":"M Wellons","year":"2012","unstructured":"Wellons M et al (2012) Early menopause predicts future coronary heart disease and stroke: the multi-ethnic study of atherosclerosis. Menopause 19(10):1081\u20131087","journal-title":"Menopause"},{"issue":"3","key":"7344_CR9","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.jtcvs.2012.12.046","volume":"146","author":"KK Singh","year":"2013","unstructured":"Singh KK et al (2013) Regulating cardiac energy metabolism and bioenergetics by targeting the DNA damage repair protein BRCA1. J Thorac Cardiovasc Surg 146(3):702\u2013709","journal-title":"J Thorac Cardiovasc Surg"},{"key":"7344_CR10","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/ncomms1601","volume":"2","author":"PC Shukla","year":"2011","unstructured":"Shukla PC et al (2011) BRCA1 is an essential regulator of heart function and survival following myocardial infarction. Nat Commun 2:593","journal-title":"Nat Commun"},{"issue":"6","key":"7344_CR11","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1016\/j.jtcvs.2013.09.060","volume":"147","author":"F Lovren","year":"2014","unstructured":"Lovren F et al (2014) BRCA1 shields vascular smooth muscle cells from oxidative stress. J Thorac Cardiovasc Surg 147(6):1946\u20131955","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"13","key":"7344_CR12","doi-asserted-by":"publisher","first-page":"e14481","DOI":"10.14814\/phy2.14481","volume":"8","author":"S Singh","year":"2020","unstructured":"Singh S et al (2020) Breast cancer susceptibility gene 2 deficiency exacerbates oxidized LDL-induced DNA damage and endothelial apoptosis. Physiol Rep 8(13):e14481","journal-title":"Physiol Rep"},{"key":"7344_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12123584","author":"A Oliverio","year":"2020","unstructured":"Oliverio A et al (2020) BRCA1\/2 variants and metabolic factors: results from a cohort of italian female carriers. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers12123584","journal-title":"Cancers (Basel)"},{"key":"7344_CR14","doi-asserted-by":"publisher","first-page":"e12545","DOI":"10.1200\/JCO.2018.36.15_suppl.e12545","volume":"36","author":"O Ivanov","year":"2018","unstructured":"Ivanov O et al (2018) Metabolic status of BRCA1 mutation carriers. J Clin Oncol 36:e12545","journal-title":"J Clin Oncol"},{"issue":"3","key":"7344_CR15","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s10549-010-0805-3","volume":"124","author":"DM van der Kolk","year":"2010","unstructured":"van der Kolk DM et al (2010) Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age. Breast Cancer Res Treat 124(3):643\u2013651","journal-title":"Breast Cancer Res Treat"},{"issue":"10120","key":"7344_CR16","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/S0140-6736(17)32520-5","volume":"391","author":"N Conrad","year":"2018","unstructured":"Conrad N et al (2018) Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals. Lancet 391(10120):572\u2013580","journal-title":"Lancet"},{"issue":"6","key":"7344_CR17","doi-asserted-by":"publisher","first-page":"3931","DOI":"10.1002\/ehf2.14103","volume":"9","author":"M Wideqvist","year":"2022","unstructured":"Wideqvist M et al (2022) Ten year age- and sex-specific temporal trends in incidence and prevalence of heart failure in Vastra Gotaland. Swed ESC Heart Fail 9(6):3931\u20133941","journal-title":"Swed ESC Heart Fail"},{"issue":"8","key":"7344_CR18","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.jchf.2018.03.006","volume":"6","author":"CW Tsao","year":"2018","unstructured":"Tsao CW et al (2018) Temporal trends in the incidence of and mortality associated with heart failure with preserved and reduced ejection fraction. JACC Heart Fail 6(8):678\u2013685","journal-title":"JACC Heart Fail"},{"issue":"41","key":"7344_CR19","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","volume":"43","author":"AR Lyon","year":"2022","unstructured":"Lyon AR et al (2022) ESC guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology And Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur Heart J 43(41):4229\u20134361","journal-title":"Eur Heart J"},{"issue":"1","key":"7344_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","volume":"28","author":"RM Lang","year":"2015","unstructured":"Lang RM et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular imaging. J Am Soc Echocardiogr 28(1):1\u201339","journal-title":"J Am Soc Echocardiogr"},{"issue":"10","key":"7344_CR21","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.echo.2015.06.011","volume":"28","author":"KE Farsalinos","year":"2015","unstructured":"Farsalinos KE et al (2015) Head-to-Head comparison of global longitudinal strain measurements among nine different vendors: the EACVI\/ASE inter-vendor comparison study. J Am Soc Echocardiogr 28(10):1171\u20131181","journal-title":"J Am Soc Echocardiogr"},{"issue":"3","key":"7344_CR22","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s11886-021-01444-z","volume":"23","author":"K Haji","year":"2021","unstructured":"Haji K, Marwick TH (2021) Clinical utility of echocardiographic strain and strain rate measurements. Curr Cardiol Rep 23(3):18","journal-title":"Curr Cardiol Rep"},{"issue":"8","key":"7344_CR23","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.clon.2022.05.001","volume":"34","author":"LD Cocco","year":"2022","unstructured":"Cocco LD et al (2022) Global longitudinal strain for the early detection of chemotherapy-induced cardiotoxicity: a systematic review and meta-analysis. Clin Oncol (R Coll Radiol) 34(8):514\u2013525","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"7344_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2023.08.011","author":"J Nyberg","year":"2023","unstructured":"Nyberg J et al (2023) Echocardiographic reference ranges of global longitudinal strain for all cardiac chambers using guideline-directed dedicated views. JACC: Cardiovasc Imaging. https:\/\/doi.org\/10.1016\/j.jcmg.2023.08.011","journal-title":"JACC: Cardiovasc Imaging"},{"issue":"3","key":"7344_CR25","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.jacc.2014.10.044","volume":"65","author":"W Kosmala","year":"2015","unstructured":"Kosmala W, Jellis CL, Marwick TH (2015) Exercise limitation associated with asymptomatic left ventricular impairment: analogy with stage B heart failure. J Am Coll Cardiol 65(3):257\u2013266","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"7344_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2010.11.006","volume":"24","author":"MH Picard","year":"2011","unstructured":"Picard MH et al (2011) American society of echocardiography recommendations for quality echocardiography laboratory operations. J Am Soc Echocardiogr 24(1):1\u201310","journal-title":"J Am Soc Echocardiogr"},{"issue":"1","key":"7344_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ehjci\/jeu184","volume":"16","author":"JU Voigt","year":"2015","unstructured":"Voigt JU et al (2015) Definitions for a common standard for 2D speckle tracking echocardiography: consensus document of the EACVI\/ASE\/industry task force to standardize deformation imaging. Eur Heart J Cardiovasc Imaging 16(1):1\u201311","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"1","key":"7344_CR28","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1161\/CIRCIMAGING.112.978031","volume":"6","author":"E Grunig","year":"2013","unstructured":"Grunig E et al (2013) Reference values for and determinants of right atrial area in healthy adults by 2-dimensional echocardiography. Circ Cardiovasc Imaging 6(1):117\u2013124","journal-title":"Circ Cardiovasc Imaging"},{"issue":"10","key":"7344_CR29","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1007\/s10554-020-01906-5","volume":"36","author":"KG Skaarup","year":"2020","unstructured":"Skaarup KG et al (2020) The impact of cardiovascular risk factors on global longitudinal strain over a decade in the general population: the Copenhagen city heart study. Int J Cardiovasc Imaging 36(10):1907\u20131916","journal-title":"Int J Cardiovasc Imaging"},{"issue":"8","key":"7344_CR30","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1093\/ejechocard\/jep097","volume":"10","author":"H Nakai","year":"2009","unstructured":"Nakai H et al (2009) Subclinical left ventricular dysfunction in asymptomatic diabetic patients assessed by two-dimensional speckle tracking echocardiography: correlation with diabetic duration. Eur J Echocardiogr 10(8):926\u2013932","journal-title":"Eur J Echocardiogr"},{"issue":"4","key":"7344_CR31","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1111\/echo.12389","volume":"31","author":"A Zoroufian","year":"2014","unstructured":"Zoroufian A et al (2014) Evaluation of subclinical left ventricular dysfunction in diabetic patients: longitudinal strain velocities and left ventricular dyssynchrony by two-dimensional speckle tracking echocardiography study. Echocardiography 31(4):456\u2013463","journal-title":"Echocardiography"},{"issue":"4","key":"7344_CR32","first-page":"327","volume":"102","author":"AL Almeida","year":"2014","unstructured":"Almeida AL et al (2014) Metabolic syndrome, strain, and reduced myocardial function: multi-ethnic study of atherosclerosis. Arq Bras Cardiol 102(4):327\u2013335","journal-title":"Arq Bras Cardiol"},{"issue":"1 Pt 2","key":"7344_CR33","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.jcmg.2018.12.035","volume":"13","author":"CM Bianco","year":"2020","unstructured":"Bianco CM et al (2020) Myocardial mechanics in patients with normal LVEF and diastolic dysfunction. JACC Cardiovasc Imaging 13(1 Pt 2):258\u2013271","journal-title":"JACC Cardiovasc Imaging"},{"issue":"10","key":"7344_CR34","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1001\/jamacardio.2019.2952","volume":"4","author":"EK Oikonomou","year":"2019","unstructured":"Oikonomou EK et al (2019) Assessment of prognostic value of left ventricular global longitudinal strain for early prediction of chemotherapy-induced cardiotoxicity: a systematic review and meta-analysis. JAMA Cardiol 4(10):1007\u20131018","journal-title":"JAMA Cardiol"},{"issue":"10","key":"7344_CR35","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.jcmg.2015.11.024","volume":"9","author":"HK Narayan","year":"2016","unstructured":"Narayan HK et al (2016) Noninvasive measures of ventricular-arterial coupling and circumferential strain predict cancer therapeutics-related cardiac dysfunction. JACC Cardiovasc Imaging 9(10):1131\u20131141","journal-title":"JACC Cardiovasc Imaging"},{"issue":"9","key":"7344_CR36","doi-asserted-by":"publisher","first-page":"6604","DOI":"10.1074\/jbc.M111.292664","volume":"287","author":"KK Singh","year":"2012","unstructured":"Singh KK et al (2012) BRCA2 protein deficiency exaggerates doxorubicin-induced cardiomyocyte apoptosis and cardiac failure. J Biol Chem 287(9):6604\u20136614","journal-title":"J Biol Chem"},{"issue":"49","key":"7344_CR37","doi-asserted-by":"publisher","first-page":"5041","DOI":"10.18632\/oncotarget.27118","volume":"10","author":"G Witberg","year":"2019","unstructured":"Witberg G et al (2019) Vascular endothelium function among male carriers of BRCA 1&2 germline mutation. Oncotarget 10(49):5041\u20135051","journal-title":"Oncotarget"},{"issue":"5","key":"7344_CR38","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1016\/j.transproceed.2015.12.141","volume":"48","author":"JK Nozynski","year":"2016","unstructured":"Nozynski JK et al (2016) BRCA1 reflects myocardial adverse remodeling in idiopathic dilated cardiomyopathy. Transplant Proc 48(5):1746\u20131750","journal-title":"Transplant Proc"},{"issue":"3","key":"7344_CR39","doi-asserted-by":"publisher","first-page":"e4812","DOI":"10.1371\/journal.pone.0004812","volume":"4","author":"PL Mai","year":"2009","unstructured":"Mai PL et al (2009) Potential excess mortality in BRCA1\/2 mutation carriers beyond breast, ovarian, prostate, and pancreatic cancers, and melanoma. PLoS ONE 4(3):e4812","journal-title":"PLoS ONE"},{"key":"7344_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/cancers10090309","author":"P Pasanisi","year":"2018","unstructured":"Pasanisi P et al (2018) A dietary intervention to lower serum levels of IGF-I in BRCA mutation carriers. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers10090309","journal-title":"Cancers (Basel)"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-024-07344-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-024-07344-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-024-07344-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T06:06:29Z","timestamp":1720418789000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-024-07344-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,8]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["7344"],"URL":"https:\/\/doi.org\/10.1007\/s10549-024-07344-4","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,8]]},"assertion":[{"value":"4 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have not disclosed any competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The Cedars-Sinai Medical Center Institutional Review Board approved this retrospective study protocol with a waiver for individual written consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}